Horiguchi et al. identified that FASN expression was increased in ccRCC and that increased FASN expression was an indicator of tumor aggressiveness and poor prognosis for ccRCC patients [33]. This evidence concerns the gene FASN and nonpapillary renal cell carcinoma.